Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
During the Height of the Opioid Epidemic, the Out-of-Pocket Price of Naloxone Increased by Over 500%
A jump in the out-of-pocket price of naloxone has likely made the lifesaving drug too expensive for most uninsured Americans.
Categorized in -
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.
Categorized in -
Association of Fatal Overdose Notification Letters With Prescription of Benzodiazepines
New research builds on a landmark USC Schaeffer Center study aimed at reducing opioid overprescribing.
Categorized in -
‘Nudges’ to Reduce Opioid Overuse Also Decrease Inappropriate Benzodiazepine Prescriptions
Informing physicians when a patient dies of an overdose may provide the needed “nudge” to improve prescribing practices.
Categorized in -
Development and Pilot Testing of EHR-Nudges to Reduce Overuse in Older Primary Care Patients
Unnecessary testing and treatment of common conditions in older adults can lead to significant morbidity and mortality.
Categorized in -
Characterization of Cannabis Products Purchased for Medical Use in New York State
Schaeffer Center researchers analyzed point-of-sale data from nearly 17,000 medical cannabis patients making 80,000 purchases.
Categorized in -
Patient Preference for Medical Cannabis Products in the Absence of Clinical Guidelines
New analysis of New York data finds considerable variability in patient product choice, even for patients with the same condition.
Categorized in -
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease
Consumers in the US are exposed to unprecedented high levels of direct-to-consumer advertising (DTCA) for prescription drugs, yet there is limited evidence regarding their effect on health-related intentions and beliefs.
Categorized in -
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
Are racial differences in symptom burden during the first year of adjuvant endocrine therapy (AET) associated with differences in adherence?
Categorized in -
Are Unequal Policies in Pre-Exposure Prophylaxis Uptake Needed to Improve Equality? An Examination Among Men Who Have Sex with Men in Los Angeles County
USC researchers examine tradeoffs between effectiveness and equality of PrEP.
Categorized in